Black Rock Inc. Accelerate Diagnostics, Inc Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.64 - $1.03 $70,995 - $114,257	-110,930 Reduced 17.11%	537,587 $435,000
Q1 2023 May 12, 2023	BUY	$0.46 - $0.77 $1,480 - $2,478	3,219 Added 0.5%	648,517 $453,000
Q4 2022 Feb 13, 2023	BUY	$0.51 - $17.1 $10,062 - $337,400	19,731 Added 3.15%	645,298 $458,000
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $59,675 - $1 Million	59,085 Added 10.43%	625,567 $951,000
Q2 2022 Aug 12, 2022	SELL	$0.54 - $1.41 $938,322 - $2.45 Million	-1,737,634 Reduced 75.41%	566,482 $562,000
Q1 2022 May 12, 2022	SELL	$1.4 - $5.15 $71,464 - $262,886	-51,046 Reduced 2.17%	2,304,116 $3.32 Million
Q4 2021 Feb 10, 2022	BUY	$4.27 - $6.97 $105,545 - $172,284	24,718 Added 1.06%	2,355,162 $12.3 Million
Q3 2021 Nov 09, 2021	BUY	$5.31 - $8.25 $14,076 - $21,870	2,651 Added 0.11%	2,330,444 $13.6 Million
Q2 2021 Aug 11, 2021	BUY	$6.81 - $9.23 $15.9 Million - $21.5 Million	2,327,793 New	2,327,793 $18.8 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.